India's stock market shows strong resilience amid global trade tensions, with robust sectoral gains and outperforming global peers, driven by solid fundamentals and a favorable macroeconomic outlook.

The Ministry of Commerce and Industry will allocate a significant portion of the second Rs. 10,000 crore (US$ 1.16 billion) Fund of Funds Scheme to support budding entrepreneurs.

India’s luxury housing market sustained its upward trajectory in Q1 2025, with sales of high-end homes priced above US$ 464,594.80 rising nearly 28% YoY across the top seven cities.

Driven by rising disposable incomes and disciplined investing, monthly Systematic Investment Plan inflows in India's mutual fund industry are expected to reach US$ 4.65 billion within 18–24 months.

India's seafood exporters are set to ship 35,000-40,000 tonnes of shrimp to the United States after a temporary tariff reduction, offering relief for delayed shipments.

India's semiconductor end-demand revenues are projected to double by 2030, while localisation opportunities are expected to contribute around US$ 13 billion.

India's hospitality industry is set for rapid growth, with over 1,00,000 new rooms expected in the next five years, marking a 20-30% increase from 2024.

India is fast becoming a global electronics manufacturing hub with rising value addition and soaring mobile exports, supported by policy reforms and reduced imports of finished goods.

Indian airport operators are set to witness 18–20% growth in FY26, driven by rising passenger traffic, tariff hikes, and higher non-aeronautical revenues, says ICRA.

President of India, Ms. Droupadi Murmu, invited Slovakian businesses to join “Make in India,” emphasising India’s economic ambitions and its role as a stable growth partner globally.

JioHotstar has become the world's third-largest video streaming service with over 200 million paid subscribers, driven by its multi-language live IPL coverage.

India’s pharmaceutical market grew 8.4% in FY25, led by strong value growth in cardiac, gastrointestinal, and anti-diabetic therapies, according to Pharmarack.